Titre (en)
Analysis
an2020
Racine
Analysis
an2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars) - Analysis (an2020)

Index « Titre (en) » - entrée « therapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
therapies < therapy < there  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000060 (2020) M L Sun [République populaire de Chine] ; J M Yang [République populaire de Chine] ; Y P Sun [République populaire de Chine] ; G H Su [République populaire de Chine][Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
000100 (2020) [Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
000174 (2020) Lieselotte Corten [Royaume-Uni] ; Brenda M. Morrow [Afrique du Sud]Use of airway clearance therapy in children hospitalised with acute lower respiratory tract infections in a South African paediatric hospital
000330 (2020) Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000506 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000598 (2020) Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde]Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
000602 (2020) Ali Rismanbaf [Iran] ; Sara Zarei [Iran]Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor
000692 (2020) Bhagirathbhai Dholaria [États-Unis] ; Bipin N. Savani [États-Unis]How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?
000734 (2020) Steven M. HeatonFrontiers in antiviral therapy and immunotherapy
000807 (2020) Yi-Hong Zhou [République populaire de Chine] ; Yuan-Yuan Qin [République populaire de Chine] ; Yan-Qiu Lu [République populaire de Chine] ; Feng Sun [République populaire de Chine] ; Sen Yang [République populaire de Chine] ; Vijay Harypursat [République populaire de Chine] ; Sheng-Quan Tang [République populaire de Chine] ; Yin-Qiu Huang [République populaire de Chine] ; Xiao-Qing He [République populaire de Chine] ; Yan-Ming Zeng [République populaire de Chine] ; Yao Li [République populaire de Chine] ; Xiao-Lei Xu [République populaire de Chine] ; Ting Zhao [République populaire de Chine] ; Yao-Kai Chen [République populaire de Chine]Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial.
000836 (2020) Jian-Sheng KangDietary restriction of amino acids for Cancer therapy
000928 (2020) Lindsey R. Baden ; Eric J. RubinCovid-19 - The Search for Effective Therapy.
000971 (2020) Long Chen [République populaire de Chine] ; Jing Xiong [République populaire de Chine] ; Lei Bao [République populaire de Chine] ; Yuan Shi [République populaire de Chine]Convalescent plasma as a potential therapy for COVID-19.
000A53 (2020) Geliang Yang [République populaire de Chine] ; Huiqing Zhang [République populaire de Chine] ; Yufei Yang [République populaire de Chine]Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19
000C55 (2020) Tian-Tian Yao [République populaire de Chine] ; Jian-Dan Qian [République populaire de Chine] ; Wen-Yan Zhu [République populaire de Chine] ; Yan Wang [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine]A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
000C82 (2020) Chunfeng Xiao [République populaire de Chine]A Novel Approach of Consultation on 2019 Novel Coronavirus (COVID-19)-Related Psychological and Mental Problems: Structured Letter Therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/Title.i -k "therapy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/Title.i  \
                -Sk "therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    therapy
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021